News Island Pharmaceuticals Limited

Equities

ILA

AU0000138869

Biotechnology & Medical Research

Delayed Australian S.E. Other stock markets 01:28:58 06/03/26 pm AEDT			5-day change	1st Jan Change
0.4150 ^AUD	0.00%		+12.16%	-3.49%

04/03	Daily Special: Island Pharmaceuticals, GenusPlus Group, Horizon Gold	FI
04/03	Island Pharmaceuticals Enters Agreement to Advance Galidesivir Approval, Shares Up 19%	MT

All News

04/03	Daily Special: Island Pharmaceuticals, GenusPlus Group, Horizon Gold	FI
04/03	Island Pharmaceuticals Enters Agreement to Advance Galidesivir Approval, Shares Up 19%	MT
02/03	Island Pharmaceuticals seeks trading halt	RE
25/02	Island Pharmaceuticals Limited Reports Earnings Results for the Half Year Ended December 31, 2025	CI
10/02	Island Pharmaceuticals Admits It Was Not Strictly in Compliance With ASX Listing Rules	MT
04/02	Island Pharmaceuticals reports placement of A$9 million at A$0.35 each	RE
04/02	Island Pharmaceuticals Says US FDA Confirms Animal Model as Development Pathway for Antiviral Drug Candidate; Shares Rise 10%	MT
04/02	Island Pharmaceuticals to Raise AU$9 Million via Placement	MT
02/02	Island Pharmaceuticals seeks trading halt	RE
07/01	Island Pharmaceuticals says US patent granted for galidesivir in Filoviridae viruses	RE
07/01	Island Pharmaceuticals Secures US Patent for Antiviral Drug Candidate; Shares Rise 12%	MT
05/01	Island Pharmaceuticals says FDA advises it requires additional time to finalise response to co's submission	RE
05/01	Island Pharmaceuticals Says US FDA Needs More Time to Review Galidesivir Submission	MT
17/12	Island Pharmaceuticals Enters Master Service Agreement With Texas Biomedical to Advance Development of Antiviral Molecule	MT
05/12	Island Pharmaceuticals Secures US Patent for Antiviral Drug; Shares Rise 7%	MT
04/12	Island Pharmaceuticals Submits Responses to US FDA for Development of Antiviral Drug; Shares Rise 8%	MT
04/12	Island Pharmaceuticals Limited Completes Additional FDA Submission to Optimise Galidesivir Development Program	CI
03/12	Island Pharmaceuticals Secures Over AU$1 Million in New Funding	MT
24/11	Island Pharmaceuticals Secures Membership to Medical Countermeasures Coalition, Shares Reach All-Time Peak	MT
17/11	Island Pharmaceuticals Says FDA Confirms Animal Rule Pathway Appropriate for Approval of Marburg Virus Countermeasures, Shares Reach All-Time Peak	MT
14/11	Island Pharmaceuticals Limited Announces Change of Address	CI
13/11	Island Pharmaceuticals seeks trading halt	RE
22/10/25	Island Pharmaceuticals Says US FDA to Provide Feedback on Antiviral Drug Candidate Approval Pathway Next Month	MT
29/09/25	Island Pharmaceuticals Advances Galidesivir Approval With FDA Submission	MT
19/09/25	Island Pharmaceuticals says FDA grants co Type C meeting under galidesivir's open IND application	RE